MedWatch

Less venture-money for zealous companies

The amount of Danish venture capital for the life science business decreased significantly in 2011 in spite of a great increase in the number of applications from financially starved companies. The question remains if the moderate optimism for 2012 will manage to hold the fort.

Foto: CHRISTOFFERSEN EMIL RYGE

Even though venture capital companies received a higher number of applications in 2011, the total investment figure of DKK 1.3 billion was down 16 % compared with 2010.

The capital drought of 2011 has especially affected companies within the life science area, which attract about 60 % of total investments.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier